Distribution of Trigeminal NERVE
Distribution of facial nerve! What are the no.1 ,2 and 3..???
1)Ophthalmic---- The ophthalmic division sends sensory information from the upper part of your face, including your forehead, scalp, and upper eyelids. 2)Maxillary---- This division communicates sensory information from the middle part of your face, including your cheeks, upper lip, and nasal cavity. 3)Mandibular---- The mandibular division has both a sensory and a motor function. It sends sensory information from your ears, lower lip, and chin. It also controls the movement of muscles within your jaw and ear.
Mr riyaz Ahmad, that is not a facial nerve it is trigeminal nerve..
Cases that would interest you
- Login to View the image
Dear Actor Vijay sir, Silambarasan sir and the respected Govt. of TamilNadu, I am tired. We are all tired. Thousands of doctors like me are tired. Health care workers are tired. Police officials are tired. Sanitary workers are tired. We have worked so hard at the ground level to make sure the damage done is kept to as low as possible amidst an unprecedented pandemic. I am not glorifying our work for I know there is nothing so great about it to the onlooker’s eyes. We don’t have cameras in front of us. We don’t do stunt sequences. We aren’t heroes. But we deserve some time to breath. We don’t want to fall prey to someone’s selfishness and greed. The pandemic isn’t over and we have people dying till today to the disease. A hundred percent theatre occupancy is a suicide attempt. Rather homicide , for none of the policy makers or the so called heroes are going to put themselves under the pump, to watch the movie amidst the crowd. This is a blatant barter system, trading lives for money. Can we please slowly try and concentrate on our lives and make sure we tide through this pandemic peacefully and not reignite the slowly burning out flame, that is still not completely put out? I wanted to make this post scientific and explain why we are still in danger. But that’s when I asked myself, “what’s the point?” Yours tiredly A poor, tired resident doctor https://www.facebook.com/aravinth.srinivas/posts/3937347876284519
Dr. Santu Das11 Likes20 Answers - Login to View the image
Hi Curofians, here are some vaccine-preventable diseases. I have prepared slides on the signs and symptoms of these diseases. It could be prevented with vaccinations. We should support the Child and Adult Immunization and spread the information to the community.
Dr. Sambhavi Gupta87 Likes57 Answers - Login to View the image
Post such a question from discussion posting page. Try now and let me know your feedback.
Dr. Santu Das12 Likes56 Answers - Login to View the image
Hello everyone, Here are some important facts about COVID-19. From Clinical presentations to treatment. Please check it out and feel free to add more points. CLINICAL PRESENTATION: In a study describing 1099 patients with COVID-19 pneumonia in Wuhan, the most common clinical features at the onset of illness were: •Fever in 88% •Fatigue in 38% •Dry cough in 67% •Myalgias in 14.9% •Dyspnea in 18.7% Pneumonia appears to be the most common and severe manifestation of infection. In this group of patients breathing difficulty developed after a median of five days of illness. Acute respiratory distress syndrome developed in 3.4% of patients. Other symptoms •Headache •Sore throat •Rhinorrhea •Gastrointestinal symptoms About 80% of confirmed COVID-19 cases suffer from only mild to moderate disease and nearly 13% have the severe disease (dyspnea, respiratory frequency ≥30/minute, blood oxygen saturation≤93%, PaO2/FiO2 ratio <300, and/or lung infiltrates >50% of the lung field within 24-48 hours). Critical illness (respiratory failure septic shock, and/or multiple organ dysfunction/failure) is noted in only in less than 6% of cases. INCUBATION PERIOD: The exact incubation period is not known. It is presumed to be between 2 to 14 days after exposure, with most cases occurring within 5 days after exposure. THE SPECTRUM OF ILLNESS SEVERITY: Most infections are self-limiting. COVID-19 tends to cause more severe illness in the elderly population or in patients with underlying medical problems. As per the report from the Chinese center for disease control and prevention that included approximately 44,500 confirmed Infections with an estimation of disease severity. • Mild illness was reported in 81% of patients. • Severe illness (Hypoxemia, >50% lung involvement on imaging within 24 to 48 hours) in 14%. • Critical Disease (Respiratory failure, shock, multi-organ dysfunction syndrome) was reported in 5 percent. • Overall case fatality rate was between 2.3 to 5%. AGE AFFECTED: • Mostly middle-aged (>30 years) and elderly. • Symptomatic infection in children appears to be uncommon, and when it occurs, it is usually mild. **The 4th version of Belgian guidance for COVID 19 is published on19th March 2020. It is one of the most precise guidelines published yet. Some points from that: 1. Chloroquine is found to have good efficacy in vitro and it reduces the duration of viral shedding. But the drug has a narrow therapeutic window and cardiac toxicity is the most limiting side effect. 2. Hydroxychloroquine is more potent and is superior to chloroquine according to the very recent Gautret’ study. 3. Azithromycin may have a viral suppressive effect, but this needs to be proved as it was noticed accidentally in 6 patients of Gautret’ study. But I think it is a good choice for coverage of bacterial pneumonia. 4. Lopinavir/Ritonavir recently shown not to provide clinical benefit in hospitalized patients with COVID-19. It may reduce ICU stay if given within 10 days of infection but not beyond. 5. Remdesivir is promising but the studies are ongoing. Also, availability is a key issue. 6. Corticosteroids are not recommended as a systemic adjunctive treatment. 7. Paracetamol is the first-line analgesic and antipyretic over NSAIDs which are used with caution. 8. No need to stop ACEIs/ARBs in non-hospitalized patients. CONSIDER changing ACEIs/ARBs to another equivalent antihypertensive in hospitalized patients. 9. Antiviral therapy is not indicated in all patients with suspected/confirmed COVID19.
Dr. Prashant Vedwan123 Likes70 Answers - Login to View the image
Care for Critically Ill Patients With COVID-19 Initial reports suggest that COVID-19 is associated with severe disease that requires intensive care in approximately 5% of proven infections. Given how common the disease is becoming, as in prior major severe acute respiratory infection outbreaks—SARS (severe acute respiratory syndrome), MERS (Middle East respiratory syndrome), avian influenza A(H7N9), and influenza A(H1N1)pdm09—critical care will be an integral component of the global response to this emerging infection. Management of severe COVID-19 is not different from management of most viral pneumonia causing respiratory failure. The principal feature of patients with severe disease is the development of ARDS: a syndrome characterized by acute onset of hypoxemic respiratory failure with bilateral infiltrates. Evidence-based treatment guidelines for ARDS should be followed, including conservative fluid strategies for patients without shock following initial resuscitation, empirical early antibiotics for suspected bacterial co-infection until a specific diagnosis is made, lung-protective ventilation, prone positioning, and consideration of extracorporeal membrane oxygenation for refractory hypoxemia. To read complete article- https://jamanetwork.com/journals/jama/fullarticle/2762996 Source- JAMA Authors- Srinivas Murthy, MD, CM, MHSc; Charles D. Gomersall, MBBS; Robert A. Fowler, MD, CM, MSc
Dr. Vivek Jain21 Likes19 Answers
2 Likes